专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

91. 发明授权

US07176180B2 Type 2 cytokine receptor and nucleic acids encoding same 失效
公开(公告)号：US07176180B2
公开(公告)日：2007-02-13
申请号：US10047264
申请日：2002-01-14
申请人： Lynette Fouser , Wei Liu , Bijia Deng
发明人： Lynette Fouser , Wei Liu , Bijia Deng
IPC分类号： A61K38/00
CPC分类号： C07K14/715 , A61K38/00 , A61K2039/505 , A61K2039/53 , C07K2319/00
摘要： The present invention provides novel isolated CRF2-12 polynucleotides and polypeptides encoded by the CRF2-12 polynucleotides. Also provided are the antibodies that immunospecifically bind to a CRF2-12 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the CRF2-12 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the CRF2-12 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.

92. 发明申请

US20060292226A1 Fatty emulsion injection of seal oil, method for preparation and the use in manufacturing intravenous injection 审中-公开
标题翻译：脂肪乳剂注射密封油，制备方法和制造静脉注射用途
公开(公告)号：US20060292226A1
公开(公告)日：2006-12-28
申请号：US10547027
申请日：2003-08-11
申请人： Wei Liu , Junxiang Liu , Weijian He , Yun Liu , Xijun Yan , Kangsen Xu
发明人： Wei Liu , Junxiang Liu , Weijian He , Yun Liu , Xijun Yan , Kangsen Xu
IPC分类号： A61K35/12 , A61K31/22
CPC分类号： A61K35/35 , A61K9/0019 , A61K9/1075 , A61K47/24
摘要： The present invention relates to a seal oil based lipid emulsion injection, and the main ingredients of which contains 190-210 g/l of refined OMEGA3 seal oil, 11-13 g/l of refined lecithin, 24-26 g/l of glycerol for injection, and balance amount of water. The preparation of the seal oil based lipid emulsion injection comprising the steps of stir and dispersion, high-pressure homogenization, vacuum filtration, antisepsis and encapsulation. The OMEGA3 seal oil lipid based emulsion injections have high content of energy, and thus are highly absorbable to human body, and can not only provide human body with caloricity, but also supply the fatty acids necessary for human body, and can enhance body's immunizing ability, reduce the content of cholesterol, adjust the blood concentration and then be used for anti-inflammation, in particular, it is highly useful for a postoperative patient to restore his strength.
摘要翻译：本发明涉及一种基于密封油的脂质乳剂注射液，其主要成分包含190-210g / l精制OMEGA3密封油，11-13g / l精制卵磷脂，24-26g / l甘油用于注射和平衡水量。密封油基脂质乳剂注射剂的制备包括搅拌和分散，高压均质，真空过滤，消毒和包封的步骤。 OMEGA3密封油脂基乳液注射剂具有高能量含量，因此对人体具有高吸收性，不仅可以为人体提供热量，还可以提供人体所需的脂肪酸，并能增强人体的免疫能力降低胆固醇含量，调节血液浓度，然后用于抗炎，特别是术后患者恢复其强度非常有用。

93. 发明申请

US20060231524A1 TECHNIQUES FOR THE USE OF AMORPHOUS CARBON (APF) FOR VARIOUS ETCH AND LITHO INTEGRATION SCHEMES 失效
标题翻译：使用不规则碳（APF）进行各种ETCH和LITHO积分方案的技术
公开(公告)号：US20060231524A1
公开(公告)日：2006-10-19
申请号：US11422031
申请日：2006-06-02
申请人： Wei Liu , Jim He , Sang Ahn , Meihua Shen , Hichem M'Saad , Wendy Yeh , Christopher Bencher
发明人： Wei Liu , Jim He , Sang Ahn , Meihua Shen , Hichem M'Saad , Wendy Yeh , Christopher Bencher
IPC分类号： C23F1/00 , B44C1/22 , G03C5/00 , H01L21/302 , C03C25/68
CPC分类号： G03F7/091 , H01L21/0276 , H01L21/0332 , H01L21/0337 , H01L21/0338 , H01L21/3081 , H01L21/3086 , H01L21/3088 , H01L21/3146
摘要： A method of etching a substrate is provided. The method of etching a substrate includes transferring a pattern into the substrate using a double patterned amorphous carbon layer on the substrate as a hardmask. Optionally, a non-carbon based layer is deposited on the amorphous carbon layer as a capping layer before the pattern is transferred into the substrate.
摘要翻译：提供蚀刻基板的方法。蚀刻基板的方法包括使用基板上的双图案化非晶碳层作为硬掩模将图案转印到基板中。任选地，在将图案转移到基底内之前，将非碳基层沉积在无定形碳层上作为覆盖层。

94. 发明申请

US20060090651A1 Multi-channel cross-flow porous device 有权
标题翻译：多通道横流多孔装置
公开(公告)号：US20060090651A1
公开(公告)日：2006-05-04
申请号：US10996522
申请日：2004-11-24
申请人： Wei Liu , Jimmie Williams , Yuming Xie
发明人： Wei Liu , Jimmie Williams , Yuming Xie
IPC分类号： B01D53/02
CPC分类号： C04B38/0074 , B01D46/0021 , B01D46/0036 , B01D46/2407 , B01D46/543 , B01D53/22 , B01D53/229 , B01D63/022 , B01D63/066 , B01D71/02 , B01D71/022 , B01D71/028 , B01D2253/108 , B01D2256/16 , B01D2257/702 , B01D2257/80 , B01D2311/13 , B01D2313/42 , B01D2315/10 , B01J12/007 , B01J19/2475 , B01J19/2485 , C01B3/38 , C01B3/503 , C01B3/505 , C01B3/56 , C01B2203/0233 , C01B2203/0244 , C01B2203/0261 , C01B2203/0405 , C01B2203/041 , C01B2203/0465 , C01B2203/047 , C01B2203/0475 , C01B2203/048 , C01B2203/0495 , C04B38/0003 , C04B2111/00793 , C04B2111/0081 , C04B35/00 , C04B38/0054 , C04B35/185
摘要： A multi-channel modular device (10) processes between two fluid streams of different compositions. The device (10) includes a porous body (150) having a first plurality of feed-flow pathways (110) disposed in the body (150) for transporting a first stream (180). A pathway wall (114) surrounds each of the first plurality of feed-flow pathways (110) for processing the first stream (180) into a first composition (1852) and a second composition (1802). At least one feed-flow inlet (1101) is disposed in the body (150) for introducing the first stream (180) into the first plurality of feed-flow pathways (110). At least one feed-flow outlet (1102) is disposed in the body (150) for discharging the remaining first stream containing the second composition (1802). At least one second pathway (210) is disposed in the body (150) for transporting a second stream (280) having a second inlet (2101) and a second outlet (2102). A networked plurality of fluid conduits (152) formed in the porous body (150) provides the flow-conduit for the second stream (280) to sweep the first composition (1852) from each of the first plurality of the feed-flow pathways (110) to the second outlet (2102). A vessel (300) ports the inlets (1101 and 2101) and outlets (1102 and 2102) to provide a second stream flow access and for spacing the body within and away from the inner surfaces of the vessel (300) to provide a gap (310) for access. A partition (350) is disposed in the gap between the body and the vessel for diverting the flow within the gap (310).
摘要翻译：多通道模块化装置（10）在不同组成的两个流体流之间进行处理。装置（10）包括具有设置在主体（150）中的第一多个进料流路（110）的多孔体（150），用于输送第一流（180）。通路壁（114）围绕第一多个进料流通道（110）中的每一个，用于将第一流（180）加工成第一组合物（1852）和第二组合物（1802）。至少一个进料流入口（1101）设置在主体（150）中，用于将第一流（180）引入第一多个进料通路（110）。至少一个进料流出口（1102）设置在主体（150）中，用于排出包含第二组合物（1802）的剩余第一流。至少一个第二通道（210）设置在主体（150）中，用于输送具有第二入口（2101）和第二出口（2102）的第二流（280）。形成在多孔体（150）中的联网的多个流体导管（152）提供用于第二流（280）的流动管道以从第一组多个进料通道（1852）中的每一个 110）连接到第二出口（2102）。容器（300）将入口（1101和2101）和出口（1102和2102）连通以提供第二流体流动通道并且用于使体内和容器（300）的内表面间隔开以提供间隙 310）进行访问。分隔件（350）设置在主体和容器之间的间隙中，用于使流体在间隙（310）内转向。

95. 发明申请

US20060043861A1 Porous glass substrate for field emission device 审中-公开
标题翻译：用于场致发射器件的多孔玻璃基板
公开(公告)号：US20060043861A1
公开(公告)日：2006-03-02
申请号：US10929123
申请日：2004-08-27
申请人： Wei Liu
发明人： Wei Liu
IPC分类号： H01J1/02 , H01J9/04 , H01J1/05
CPC分类号： H01J1/304 , B82Y10/00 , H01J9/025 , H01J2201/30469 , H01J2329/00
摘要： An improved process for growing carbon nanotubes includes steps of providing a glass substrate that has a porous surface, depositing a catalyst into the pores on the porous surface, and growing carbon nanotubes on the substrate. Desirably, the carbon nanotubes are grown using a chemical vapor deposition technique in which the direction of flow of a carbon precursor gas (and any optional diluent gases) is aligned with the desired direction of growth propagation. The techniques of the invention provide a field emission device having more uniformly aligned carbon nanotubes and/or more uniformly sized carbon nanotubes.
摘要翻译：用于生长碳纳米管的改进方法包括提供具有多孔表面的玻璃基底，在多孔表面上的孔中沉积催化剂和在基底上生长碳纳米管的步骤。期望地，使用化学气相沉积技术来生长碳纳米管，其中碳前体气体（和任何任选的稀释气体）的流动方向与所需的生长传播方向对准。本发明的技术提供了具有更均匀排列的碳纳米管和/或更均匀尺寸的碳纳米管的场致发射器件。

96. 发明申请

US20060041110A1 ENZYMATIC TEMPLATE POLYMERIZATION 失效
标题翻译：酶模式聚合
公开(公告)号：US20060041110A1
公开(公告)日：2006-02-23
申请号：US10324736
申请日：2002-12-19
申请人： Lynne Samuelson , Ferdinando Bruno , Sukant Tripathy , Susan Tripathy , Ramaswamy Nagarajan , Jayant Kumar , Wei Liu
发明人： Lynne Samuelson , Ferdinando Bruno , Sukant Tripathy , Susan Tripathy , Ramaswamy Nagarajan , Jayant Kumar , Wei Liu
IPC分类号： C07H21/04 , C07H21/02
CPC分类号： C08G73/0266 , H01B1/128 , Y10S977/704 , Y10T436/143333
摘要： A conductive polymer is formed enzymatically in the presence of a polynucleotide template. The method includes combining at least one redox monomer with a polynucleotide template and a redox enzyme, such as horseradish peroxidase, to form a reaction mixture. The monomer aligns along the template before or during the polymerization. Therefore, the polynucleotide template thereby affects the molecular weight and conformation of the conductive polymer. When the conductive polymer is complexed to a polynucleotide duplex, the conformation of the polynucleotide duplex can be modulated by changing the oxidation state of the conductive polymer.
摘要翻译：在多核苷酸模板的存在下，酶促形成导电聚合物。该方法包括将至少一种氧化还原单体与多核苷酸模板和氧化还原酶如辣根过氧化物酶组合以形成反应混合物。在聚合之前或聚合过程中，单体沿着模板排列。因此，多核苷酸模板因此影响导电聚合物的分子量和构象。当导电聚合物与多核苷酸双链体复合时，可通过改变导电聚合物的氧化态来调节多核苷酸双链体的构象。

97. 发明申请

US20050282168A1 Cell surface molecules as markers and therapeutic agents against kidney cancers 审中-公开
标题翻译：细胞表面分子作为肾癌的标志物和治疗剂
公开(公告)号：US20050282168A1
公开(公告)日：2005-12-22
申请号：US10671740
申请日：2003-09-29
申请人： Wei Liu , Maryann Whitley , Donna Slonim , Steven Howes
发明人： Wei Liu , Maryann Whitley , Donna Slonim , Steven Howes
IPC分类号： A61K47/48 , G01N33/574 , C12Q1/68
CPC分类号： G01N33/57438 , A61K47/6809 , A61K47/6849 , G01N2333/70596
摘要： Human cell surface molecules CD70 and CD203c are expressed at higher levels in kidney carcinomas, particularly renal cell carcinomas and clear cell renal cell carcinomas, yet are expressed at low levels in normal kidney and other diseased kidney tissue, and at low levels in other tissues. CD70 and CD203c show specificity towards kidney carcinomas, particularly renal cell carcinomas and clear cell renal cell carcinomas and thus can be used as diagnostic markers and therapeutic targets for these diseases. In addition, antibodies or small molecules against these molecules could be used in treatments towards these diseases.
摘要翻译：人类细胞表面分子CD70和CD203c在肾癌，特别是肾细胞癌和透明细胞肾细胞癌中的表达水平较高，但在正常肾脏和其他患病肾组织中表达较低，而在其他组织中呈低水平。 CD70和CD203c对肾癌，特别是肾细胞癌和透明细胞肾细胞癌具有特异性，因此可用作这些疾病的诊断标志物和治疗靶标。此外，针对这些分子的抗体或小分子可用于治疗这些疾病。

98. 发明申请

US20050273596A1 Architecture and design for central authentication and authorization in an on-demand utility environment using a secured global hashtable 失效
标题翻译：在使用安全的全球散列表的按需实用程序环境中进行中央身份验证和授权的架构和设计
公开(公告)号：US20050273596A1
公开(公告)日：2005-12-08
申请号：US10850398
申请日：2004-05-20
申请人： Messaoud Benantar , Yen-Fu Chen , John Dunsmoir , Randolph Forlenza , Wei Liu , Sandra Schlosser
发明人： Messaoud Benantar , Yen-Fu Chen , John Dunsmoir , Randolph Forlenza , Wei Liu , Sandra Schlosser
IPC分类号： H04L29/06 , H04L9/00
CPC分类号： H04L63/0823 , H04L63/0407 , H04L63/14
摘要： A Centralized Authentication & Authorization (CAA) system that prevents unauthorized access to client data using a secure global hashtable residing in the application server in a web services environment. CAA comprises a Service Request Filter (SRF) and Security Program (SP). The SRF intercepts service requests, extracts the service client's identifier from a digital certificate attached to the request, and stores the identifier in memory accessible to service providers. The client identifier is secured by the SP using a key unique to the client identifier. When the web services manager requests the client identifier, the web services manager must present the key to the SP in order to access the client identifier. Thus, the present invention prevents a malicious user from attempting to obtain sensitive data within the application server once the malicious user has gained access past the firewall.
摘要翻译：集中式身份验证和授权（CAA）系统，可以防止使用位于Web服务环境中的应用程序服务器中的安全全局散列表来对客户端数据进行未经授权的访问。 CAA包括服务请求过滤器（SRF）和安全程序（SP）。 SRF拦截服务请求，从附加到请求的数字证书中提取服务客户端的标识符，并将该标识符存储在服务提供商可访问的存储器中。客户端标识符由SP使用客户端标识符唯一的密钥保护。当Web服务管理器请求客户端标识符时，Web服务管理器必须向SP呈现密钥以访问客户端标识符。因此，本发明防止恶意用户一旦恶意用户已经通过防火墙访问，就试图获取应用服务器内的敏感数据。

99. 发明授权

US06960416B2 Method and apparatus for controlling etch processes during fabrication of semiconductor devices 失效
标题翻译：用于在半导体器件制造期间控制蚀刻工艺的方法和装置
公开(公告)号：US06960416B2
公开(公告)日：2005-11-01
申请号：US10428145
申请日：2003-05-01
申请人： David S L Mui , Wei Liu , Hiroki Sasano
发明人： David S L Mui , Wei Liu , Hiroki Sasano
IPC分类号： G03F7/20 , H01L21/66 , G01B11/02
CPC分类号： G03F7/70625 , H01L21/67207 , H01L21/67253 , H01L22/20
摘要： A method for controlling etch processes during fabrication of semiconductor devices comprises tests and measurements performed on non-product and product substrates to define an N-parameter CD control graph that is used to calculate a process time for trimming a patterned mask to a pre-determined width. An apparatus for performing such a method.
摘要翻译：一种用于在半导体器件制造期间控制蚀刻工艺的方法包括对非产品和产品基底进行的测试和测量，以定义N参数CD控制图，其用于计算用于将图案化掩模修剪到预定的处理时间宽度。一种用于执行这种方法的装置。

100. 发明申请

US20050190381A1 Method and apparatus for controlling a calibration cycle or a metrology tool 失效
标题翻译：用于控制校准周期或计量工具的方法和装置
公开(公告)号：US20050190381A1
公开(公告)日：2005-09-01
申请号：US10788498
申请日：2004-02-26
申请人： David Mui , Hiroki Sasano , Wei Liu
发明人： David Mui , Hiroki Sasano , Wei Liu
IPC分类号： G01B11/06 , G01B11/24 , G01B11/28 , H01L21/66
CPC分类号： G01B11/0616 , G01B11/24 , H01L22/20
摘要： A method and apparatus for controlling when a calibration cycle is started for a metrology tool. The method and apparatus exploits a correlation between a drift of a first parameter (e.g., film thickness measurement drift) and a drift of a second parameter (e.g., CD measurement drift). One embodiment of the method comprises measuring a film thickness on one or more reference substrates to determine when a drift component of these measurements exceeds a pre-determined range and thereafter calibrating the metrology tool when the drift component of the film thickness measurements exceeds the pre-determined range. Generally, the drift of the film thickness measurement will occur prior to substantial drift of the CD measurement occurring.
摘要翻译：一种用于控制计量工具何时开始校准周期的方法和装置。该方法和装置利用第一参数的漂移（例如，膜厚度测量漂移）和第二参数的漂移（例如，CD测量漂移）之间的相关性。该方法的一个实施例包括测量一个或多个参考基底上的膜厚度，以确定这些测量的漂移分量何时超过预定范围，然后当膜厚度测量的漂移分量超过预定范围时校准测量工具，确定范围。通常，膜厚度测量的漂移将发生在发生CD测量的实质漂移之前。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式